Premium
Diminished inhibitory efficacy of GABA on PVN neurons in AngII‐salt hypertension reflects a KCC2‐independent increase of intracellular Cl‐ concentration
Author(s) -
Yamaguchi Junya,
Truong Tamara,
Andrade Mary,
Toney Glenn
Publication year - 2021
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.2021.35.s1.04125
Subject(s) - inhibitory postsynaptic potential , medicine , forebrain , gabaergic , chemistry , glutamatergic , endocrinology , glutamate receptor , excitatory postsynaptic potential , angiotensin ii , blood pressure , biology , receptor , central nervous system
The hypothalamic PVN receives glutamatergic excitation from sodium and AngII sensing regions of the forebrain along with dense GABAergic inhibition from the surrounding peri‐nuclear zone (PNZ). Previously, we found that synaptic glutamate release in PVN enhances GABA inhibition, but whether forebrain inputs can do so in the setting of hypertension (HTN) is unknown. Studies indicate that a high salt diet alone does not raise mean arterial pressure (MAP), while AngII treatment raises MAP in proportion to the level of salt intake. This suggests that whereas excitatory inputs to PVN driven by high salt intake alone cannot overcome PVN GABA inhibition, AngII driven inputs can. The notion that GABA inhibition of PVN is strengthened forebrain inputs in AngII‐salt HTN is contrary to a prior report that GABA inhibition in AngII‐salt HTN is reduced. To reconcile these seemingly disparate findings, we compared mechanisms regulating PVN GABA inhibition in mice consuming a normal salt (0.4% NaCl) diet (NSD), a high salt (4% NaCl) diet (HSD) or a HSD with AngII (600 ng/kg/min, s.c.) infusion (AngII‐salt HTN). Using gramicidin perforated patch recordings, we determined that the GABA equilibrium potential (E GABA ) of PVN neurons was not different between NSD (‐67.2 ± 6.3 mV, n=3 cells) and HSD (‐53.7 ± 15.6 mV, n=4 cells) mice, but was significantly depolarized in mice with AngII‐salt HTN (‐32.9 ± 8.8 mV, n=6 cells)(P=0.0033). This indicates that in AngII‐salt HTN the inhibitory effect of GABA on PVN neurons decreases as [Cl‐]i increases. Normally, [Cl‐]i is held low by activities of KCC2 and NKCC1, which promote neuronal Cl‐ efflux and influx, respectively. In brain slices, KCC2 inhibition (VU0463271, 10 µM) rapidly depolarized PVN E GABA , consistent with blunting of GABA inhibition. Accordingly, PVN inhibition of KCC2 (VU0463271, 100 pmol, 25 nL) in vivo increased renal SNA, suggesting GABA was switched from an inhibitory to an excitatory transmitter. Consistent with this, PVN GABA‐AR activation (muscimol, 50 pmol, 25 nL) during KCC2 inhibition increased renal SNA. Thus, KCC2 appears critical for maintaining low [Cl‐]i and a hyperpolarized EGABA in PVN. In light of this, it would seem likely that elevated PVN [Cl‐]i in AngII‐salt HTN reflects a relative loss of KCC2 Cl‐ efflux. To investigate this, western blot analysis of PVN punches was performed and revealed that expression of KCC2 and NKCC1 was increased and decreased, respectively, both in mice consuming a HSD alone and mice with AngII‐salt HTN. These changes were unexpected as they are predicted to drive [Cl‐]i low, not high. Therefore, expression changes appear aimed at buffering elevated [Cl‐]i caused by an alternative mechanism, possibly excess Cl‐ influx through GABA‐AR, reflecting increased, not decreased, GABA release in AngII‐salt HTN. Similar expression changes in HSD mice suggests that high salt intake generates a permissive state of Cl‐ ionic plasticity that blunts PVN GABA inhibition and facilitates AngII‐salt HTN.